SYBODY
Live / Registered — Registered (as of 30 Nov 2021)
What this means for you
Registered since 30 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79279166
- Registration number
- 6571257
- Mark type
- Stylized text
- Filed
- 20 Dec 2019
- Published for opposition
- 14 Sept 2021
- Registered
- 30 Nov 2021
- Attorney of record
- Julie Reitz
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific and research purposes; diagnostic reagents for scientific and research purposes; diagnostic preparations for scientific use, namely, molecules, antibodies, nanobodies, peptides, target molecules; chemical and biochemical substances for in vitro and in vivo scientific use; chemical materials, namely, chemical agents for chelating and sequestering, rheology modifiers for use in the field of coating materials and chemical preparations, namely, chemical preparations for scientific purposes, industrial chemicals and natural elements, namely, diamond molecules for use in pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, novel therapeutic antibodies; medical and veterinary preparations in the nature of vaccines; bacterial preparations for medical and veterinary use; medical preparations for the treatment of gout; veterinary preparations for treatment of intestinal bacteria; hygienic products for medical use, namely, disinfectants for medical hygienic purposes; all of the aforementioned exclude vitamin supplements
- Class 042 — Scientific and technological services: Scientific research services for identification and quantification of molecules, in particular polypeptides, from a series of molecules; scientific research services using a series of bar codes for identifying molecules selected by mass spectrometry; scientific analyses in the field of molecular biology; consultancy in the field of technological research in the area of diagnostic preparations; scientific advice relating to research and development in the field of therapeutic procedures; consulting services in the field of pharmaceutical research; consulting services for gene therapy research; provision of scientific information and data relating to medical and veterinary product research and development; biochemical and biotechnological research and development; research, testing and computer-aided scientific analysis in the field of pharmaceuticals and biochemicals; scientific research in the field of proteins, antibodies, microorganisms and cells; computer software development
Owner
- Linkster Therapeutics AG, CH
- Linkster Therapeutics AG, CH
- Linkster Therapeutics AG, CH
- Roger Dawson, CH
- Iwan Zimmermann, CH
- Pascal Egloff, XP
Prosecution history
- 18 Dec 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Jul 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Jun 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 May 2022 — FINAL DISPOSITION PROCESSED
- 28 Feb 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Sept 2021 — PUBLISHED FOR OPPOSITION
- 26 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Aug 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB